Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

National Institute of Mental Health, Dhaka

🇧🇩Bangladesh

Country: 🇧🇩Bangladesh

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Impact on Anxiety and Motivation of COVID-19 and Predictors of Individual Responses

Completed

Conditions: Anxiety
Healthy Volunteers

Interventions: Behavioral: Computer task questionnaires

First Posted Date: 2020-05-06

Last Posted Date: 2025-05-31

Lead Sponsor: National Institute of Mental Health (NIMH)

Target Recruit Count: 2962

Registration Number: NCT04377100

Locations: 🇺🇸
National Institute of Mental Health (NIMH), Bethesda, Maryland, United States

Mental Health Impact of COVID-19 Pandemic on NIMH Research Participants and Volunteers

Completed

Conditions: Anxiety Disorder
Healthy Volunteer
Preexisting Medical Condition
Mood Disorder

First Posted Date: 2020-04-09

Last Posted Date: 2023-04-28

Lead Sponsor: National Institute of Mental Health (NIMH)

Target Recruit Count: 3655

Registration Number: NCT04339790

Locations: 🇺🇸
National Institute of Mental Health (NIMH), Bethesda, Maryland, United States

Ask Suicide-Screening Questions (ASQ) for Youth With Autism Spectrum and Neurodevelopmental Disorders

Active, not recruiting

Conditions: Suicidal Ideation

First Posted Date: 2020-03-23

Last Posted Date: 2025-07-02

Lead Sponsor: National Institute of Mental Health (NIMH)

Target Recruit Count: 278

Registration Number: NCT04317118

Locations: 🇺🇸
Kennedy Krieger Institute/Johns Hopkins University, Baltimore, Maryland, United States
🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
🇺🇸
Nationwide Children's Hospital/ Ohio State University, Columbus, Ohio, United States

Mechanism of Action Underlying Ketamine's Antidepressant Effects: The AMPA Throughput Theory in Patients With Treatment-Resistant Major Depression

Phase 1

Recruiting

Conditions: Major Depression
Depression
Major Depressive Disorder

Interventions: Device: Arm 1, 2, 3 device interventions
Drug: Arm 1, 2, 3 drug Interventions
Other: Arm 2 Interventions
Drug: Arm 1 and 2 Interventions

First Posted Date: 2019-06-04

Last Posted Date: 2025-06-22

Lead Sponsor: National Institute of Mental Health (NIMH)

Target Recruit Count: 70

Registration Number: NCT03973268

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

PET Imaging of Neuroinflammation in Neurodegenerative Diseases Via a Novel Translocator Protein (TSPO) Radioligand

Phase 1

Terminated

Conditions: Dementia

Interventions: Drug: 11C-ER176
Drug: 11C-PIB
Diagnostic Test: Positron Emission Tomography (PET) Scan

First Posted Date: 2019-05-22

Last Posted Date: 2024-05-01

Lead Sponsor: National Institute of Mental Health (NIMH)

Target Recruit Count: 13

Registration Number: NCT03958630

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Novel PET Radioligand as an Inflammatory Biomarker in Musculoskeletal Conditions

Phase 1

Active, not recruiting

Conditions: Rheumatoid Arthritis
Myositis
Inflammatory
Healthy Volunteers

Interventions: Diagnostic Test: 11C-MC1
Drug: Celecoxib

First Posted Date: 2019-04-11

Last Posted Date: 2025-03-30

Lead Sponsor: National Institute of Mental Health (NIMH)

Target Recruit Count: 30

Registration Number: NCT03912428

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Title: Safety and Feasibility of Individualized Low Amplitude Seizure Therapy (iLAST)

Phase 1

Withdrawn

Conditions: Unipolar Depression

Interventions: Device: MagPro TMS stimulator and coil
Device: MRI
Device: MECTA paired with the 4X1 HD-ECT

First Posted Date: 2019-03-29

Last Posted Date: 2025-02-27

Lead Sponsor: National Institute of Mental Health (NIMH)

Target Recruit Count: 20

Registration Number: NCT03895658

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Title: Evaluation of a Novel PET Radioligand for Phosphodiesterase-4D (PDE4D)

Phase 1

Completed

Conditions: Depression

Interventions: Drug: [C-11]T-1650
Drug: BPN14770

First Posted Date: 2019-03-04

Last Posted Date: 2021-03-22

Lead Sponsor: National Institute of Mental Health (NIMH)

Target Recruit Count: 3

Registration Number: NCT03861000

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Effects of an ER Beta Agonist (Lilly Compound LY500307) on Estradiol-Withdrawal-Induced Mood Symptoms in Women With Past Perimenopausal Depression

Phase 2

Completed

Conditions: Perimenopause-Related Depression

Interventions: Drug: ER beta agonist
Other: Placebo

First Posted Date: 2018-09-28

Last Posted Date: 2024-10-18

Lead Sponsor: National Institute of Mental Health (NIMH)

Target Recruit Count: 68

Registration Number: NCT03689543

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Evaluation of a Novel PET Radioligand to Image OGA

Completed

Conditions: Pharmacokinetics
Adult

Interventions: Drug: 18F-OGA-1

First Posted Date: 2018-08-15

Last Posted Date: 2019-06-28

Lead Sponsor: National Institute of Mental Health (NIMH)

Target Recruit Count: 28

Registration Number: NCT03632226

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy